Explore our materials

International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021

Low-level viremia is associated with lower cumulative adherence to antiretroviral therapy in persons with HIV

International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021

Using PBPK modelling to estimate lamivudine exposure in children with abnormal kidney function

International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021

Charles Boucher Memorial Lecture

International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021

John Gerber Memorial Lecture

International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021

Transporters Expression in Brain and Other Tissues I Session: John Gerber Memorial Lecture

International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021

Applications and Challenges of ML and AI for Pharmacogenomics

International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021

Imaging Drug Disposition in Tissues for PK/PD

International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021

Debate: TAF versus TDF - TDF Advocate

International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021

LA Controversies: Need for Oral Lead-In and How to Cover Tail of Injectable LA Regimens

International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021

Special Populations Including End Organ Failure: Focus on Long-Acting Cabotegravir and Rilpivirine

International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021

DDIs